Adaptive radiotherapy for head and neck cancer - Dosimetric results from a prospective clinical trial

David Schwartz, Adam S. Garden, Shalin J. Shah, Gregory Chronowski, Samir Sejpal, David I. Rosenthal, Yipei Chen, Yongbin Zhang, Lifei Zhang, Pei Fong Wong, John A. Garcia, K. Kian Ang, Lei Dong

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Purpose: To conduct a clinical trial evaluating adaptive head and neck radiotherapy (ART). Methods: Patients with locally advanced oropharyngeal cancer were prospectively enrolled. Daily CT-guided setup and deformable image registration permitted mapping of dose to avoidance structures and CTVs. We compared four planning scenarios: (1) original IMRT plan aligned daily to marked isocenter (BB); (2) original plan aligned daily to bone (IGRT); (3) IGRT with one adaptive replan (ART1); and (4) actual treatment received by each study patient (IGRT with one or two adaptive replans, ART2). Results: All 22 study patients underwent one replan (ART1); eight patients had two replans (ART2). ART1 reduced mean dose to contralateral parotid by 0.6 Gy or 2.8% (paired t-test; p = 0.003) and ipsilateral parotid by 1.3 Gy (3.9%) (p = 0.002) over the IGRT alone. ART2 further reduced the mean contralateral parotid dose by 0.8 Gy or 3.8% (p = 0.026) and ipsilateral parotid by 4.1 Gy or 9% (p = 0.001). ART significantly reduced integral body dose. Conclusions: This pilot trial suggests that head and neck ART dosimetrically outperforms IMRT. IGRT that leverages conventional PTV margins does not improve dosimetry. One properly timed replan delivers the majority of achievable dosimetric improvement. The clinical impact of ART must be confirmed by future trials.

Original languageEnglish (US)
Pages (from-to)80-84
Number of pages5
JournalRadiotherapy and Oncology
Volume106
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Head and Neck Neoplasms
Neck
Radiotherapy
Clinical Trials
Head
Oropharyngeal Neoplasms
Bone and Bones
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Adaptive radiotherapy for head and neck cancer - Dosimetric results from a prospective clinical trial. / Schwartz, David; Garden, Adam S.; Shah, Shalin J.; Chronowski, Gregory; Sejpal, Samir; Rosenthal, David I.; Chen, Yipei; Zhang, Yongbin; Zhang, Lifei; Wong, Pei Fong; Garcia, John A.; Kian Ang, K.; Dong, Lei.

In: Radiotherapy and Oncology, Vol. 106, No. 1, 01.01.2013, p. 80-84.

Research output: Contribution to journalArticle

Schwartz, D, Garden, AS, Shah, SJ, Chronowski, G, Sejpal, S, Rosenthal, DI, Chen, Y, Zhang, Y, Zhang, L, Wong, PF, Garcia, JA, Kian Ang, K & Dong, L 2013, 'Adaptive radiotherapy for head and neck cancer - Dosimetric results from a prospective clinical trial', Radiotherapy and Oncology, vol. 106, no. 1, pp. 80-84. https://doi.org/10.1016/j.radonc.2012.10.010
Schwartz, David ; Garden, Adam S. ; Shah, Shalin J. ; Chronowski, Gregory ; Sejpal, Samir ; Rosenthal, David I. ; Chen, Yipei ; Zhang, Yongbin ; Zhang, Lifei ; Wong, Pei Fong ; Garcia, John A. ; Kian Ang, K. ; Dong, Lei. / Adaptive radiotherapy for head and neck cancer - Dosimetric results from a prospective clinical trial. In: Radiotherapy and Oncology. 2013 ; Vol. 106, No. 1. pp. 80-84.
@article{95c23c0b82104080bfaa1b56113f0acd,
title = "Adaptive radiotherapy for head and neck cancer - Dosimetric results from a prospective clinical trial",
abstract = "Purpose: To conduct a clinical trial evaluating adaptive head and neck radiotherapy (ART). Methods: Patients with locally advanced oropharyngeal cancer were prospectively enrolled. Daily CT-guided setup and deformable image registration permitted mapping of dose to avoidance structures and CTVs. We compared four planning scenarios: (1) original IMRT plan aligned daily to marked isocenter (BB); (2) original plan aligned daily to bone (IGRT); (3) IGRT with one adaptive replan (ART1); and (4) actual treatment received by each study patient (IGRT with one or two adaptive replans, ART2). Results: All 22 study patients underwent one replan (ART1); eight patients had two replans (ART2). ART1 reduced mean dose to contralateral parotid by 0.6 Gy or 2.8{\%} (paired t-test; p = 0.003) and ipsilateral parotid by 1.3 Gy (3.9{\%}) (p = 0.002) over the IGRT alone. ART2 further reduced the mean contralateral parotid dose by 0.8 Gy or 3.8{\%} (p = 0.026) and ipsilateral parotid by 4.1 Gy or 9{\%} (p = 0.001). ART significantly reduced integral body dose. Conclusions: This pilot trial suggests that head and neck ART dosimetrically outperforms IMRT. IGRT that leverages conventional PTV margins does not improve dosimetry. One properly timed replan delivers the majority of achievable dosimetric improvement. The clinical impact of ART must be confirmed by future trials.",
author = "David Schwartz and Garden, {Adam S.} and Shah, {Shalin J.} and Gregory Chronowski and Samir Sejpal and Rosenthal, {David I.} and Yipei Chen and Yongbin Zhang and Lifei Zhang and Wong, {Pei Fong} and Garcia, {John A.} and {Kian Ang}, K. and Lei Dong",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.radonc.2012.10.010",
language = "English (US)",
volume = "106",
pages = "80--84",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Adaptive radiotherapy for head and neck cancer - Dosimetric results from a prospective clinical trial

AU - Schwartz, David

AU - Garden, Adam S.

AU - Shah, Shalin J.

AU - Chronowski, Gregory

AU - Sejpal, Samir

AU - Rosenthal, David I.

AU - Chen, Yipei

AU - Zhang, Yongbin

AU - Zhang, Lifei

AU - Wong, Pei Fong

AU - Garcia, John A.

AU - Kian Ang, K.

AU - Dong, Lei

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Purpose: To conduct a clinical trial evaluating adaptive head and neck radiotherapy (ART). Methods: Patients with locally advanced oropharyngeal cancer were prospectively enrolled. Daily CT-guided setup and deformable image registration permitted mapping of dose to avoidance structures and CTVs. We compared four planning scenarios: (1) original IMRT plan aligned daily to marked isocenter (BB); (2) original plan aligned daily to bone (IGRT); (3) IGRT with one adaptive replan (ART1); and (4) actual treatment received by each study patient (IGRT with one or two adaptive replans, ART2). Results: All 22 study patients underwent one replan (ART1); eight patients had two replans (ART2). ART1 reduced mean dose to contralateral parotid by 0.6 Gy or 2.8% (paired t-test; p = 0.003) and ipsilateral parotid by 1.3 Gy (3.9%) (p = 0.002) over the IGRT alone. ART2 further reduced the mean contralateral parotid dose by 0.8 Gy or 3.8% (p = 0.026) and ipsilateral parotid by 4.1 Gy or 9% (p = 0.001). ART significantly reduced integral body dose. Conclusions: This pilot trial suggests that head and neck ART dosimetrically outperforms IMRT. IGRT that leverages conventional PTV margins does not improve dosimetry. One properly timed replan delivers the majority of achievable dosimetric improvement. The clinical impact of ART must be confirmed by future trials.

AB - Purpose: To conduct a clinical trial evaluating adaptive head and neck radiotherapy (ART). Methods: Patients with locally advanced oropharyngeal cancer were prospectively enrolled. Daily CT-guided setup and deformable image registration permitted mapping of dose to avoidance structures and CTVs. We compared four planning scenarios: (1) original IMRT plan aligned daily to marked isocenter (BB); (2) original plan aligned daily to bone (IGRT); (3) IGRT with one adaptive replan (ART1); and (4) actual treatment received by each study patient (IGRT with one or two adaptive replans, ART2). Results: All 22 study patients underwent one replan (ART1); eight patients had two replans (ART2). ART1 reduced mean dose to contralateral parotid by 0.6 Gy or 2.8% (paired t-test; p = 0.003) and ipsilateral parotid by 1.3 Gy (3.9%) (p = 0.002) over the IGRT alone. ART2 further reduced the mean contralateral parotid dose by 0.8 Gy or 3.8% (p = 0.026) and ipsilateral parotid by 4.1 Gy or 9% (p = 0.001). ART significantly reduced integral body dose. Conclusions: This pilot trial suggests that head and neck ART dosimetrically outperforms IMRT. IGRT that leverages conventional PTV margins does not improve dosimetry. One properly timed replan delivers the majority of achievable dosimetric improvement. The clinical impact of ART must be confirmed by future trials.

UR - http://www.scopus.com/inward/record.url?scp=84874665859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874665859&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2012.10.010

DO - 10.1016/j.radonc.2012.10.010

M3 - Article

VL - 106

SP - 80

EP - 84

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 1

ER -